HKEX eyes more global biotechs to build IPO hub | FinanceAsia

The trend of initial public offerings (IPOs) of foreign biotech firms on the Hong Kong Stock Exchange (HKEX), though nascent, has the potential to take the Asian financial hub to a higher level internationally.

Also Read

Nvidia’s blockbuster results fail to dazzle investors

Q3 growth seen above 7%: Festive demand lifts economy, but revisions loom

D Forbes-Edelen on Why AI Is Redefining Value for Women in Transition

Plugin developed by ProSEOBlogger. Get free gpl themes.

¬ Haymarket Media Limited. All rights reserved.